Dr Reddy's Laboratories - 17 Year Stock Price History | RDY

Historical daily share price chart and data for Dr Reddy's Laboratories since 2001 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Dr Reddy's Laboratories as of September 25, 2018 is 35.47.
Dr Reddy's Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 33.0678 37.7583 39.1957 28.2419 35.4700 -4.73%
2017 38.4308 44.7075 45.9472 29.8478 37.2329 -16.42%
2016 45.3363 44.6660 53.3952 40.3315 44.5501 -1.64%
2015 54.9614 48.7679 66.3288 42.6113 45.2922 -7.75%
2014 44.9451 38.9658 56.8261 37.3897 49.0988 23.76%
2013 35.3684 32.8266 39.8263 30.7527 39.6716 24.12%
2012 30.3414 28.7162 33.3926 26.1065 31.9625 14.03%
2011 31.8363 34.6510 36.4239 27.6875 28.0304 -18.30%
2010 28.4355 22.9165 38.7630 21.4981 34.3075 53.85%
2009 14.1316 9.3318 24.0679 6.7726 22.2994 148.96%
2008 12.1047 16.6010 16.6010 6.8823 8.9571 -45.69%
2007 14.7830 16.3467 16.7802 13.1044 16.4921 0.34%
2006 13.7682 9.8064 17.1477 9.8064 16.4370 69.17%
2005 8.1286 8.8134 9.8289 6.7576 9.7164 9.63%
2004 9.1009 14.3011 14.6609 6.7397 8.8626 -36.95%
2003 10.1112 8.6911 14.2745 7.8246 14.0568 64.50%
2002 8.4380 8.4640 10.4918 6.0829 8.5452 2.29%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.816B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $63.809B 10.95
Teva Pharmaceutical Industries (TEVA) Israel $24.263B 6.78
Mylan (MYL) United Kingdom $19.690B 8.38
Bausch Health Cos (BHC) Canada $8.691B 6.47
Supernus Pharmaceuticals (SUPN) United States $2.585B 27.65
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.441B 4.15
Akorn (AKRX) United States $1.632B 8.08
Assembly Biosciences (ASMB) United States $0.951B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.896B 129.20
Homology Medicines (FIXX) United States $0.856B 0.00
CymaBay Therapeutics (CBAY) United States $0.654B 0.00
Voyager Therapeutics (VYGR) United States $0.591B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.520B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.486B 0.00
Corium (CORI) United States $0.339B 0.00
Teligent (TLGT) United States $0.205B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.146B 0.00
Sol-Gel Technologies (SLGL) Israel $0.137B 0.00
Aevi Genomic Medicine (GNMX) United States $0.077B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.068B 0.00
Evoke Pharma (EVOK) United States $0.054B 0.00
Versartis (VSAR) United States $0.051B 0.00
Acasti Pharma (ACST) Canada $0.031B 0.00
Agile Therapeutics (AGRX) United States $0.012B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.011B 0.00
China Pharma Holdings (CPHI) China $0.009B 0.00